WKL Wolters Kluwer NV

Austin Regional Clinic Implements Wolters Kluwer’s UpToDate Anywhere for Streamlined Access to Clinical Decision Support within EMR

The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that Austin Regional Clinic (ARC) has implemented UpToDate® Anywhere, with easy access within the Epic electronic medical record (EMR) they use every day.

The integration helps deliver evidence-based information directly to the point of care. “Most of our team members feel that UpToDate is a gold standard source of information,” said Dr. Manish Naik, Chief Medical Information Officer and a member of the ARC Executive Board. “As long-time users of UpToDate, it was important to make access to UpToDate as easy as possible, so our clinicians can immediately get the answer to a clinical question while meeting with a patient. I use it regularly in my practice.”

Austin Regional Clinic is a multispecialty medical group that provides comprehensive healthcare services to more than 430,000 area residents, with 21 locations in seven cities throughout the greater Austin area.

“In the typical patient visit, physicians are expected to do so many tasks beyond patient care, such as considering meaningful use criteria and closing care gaps,” said Dr. Naik. “As we move further along the continuum of value-based care, we know that incorporating an authoritative clinical decision support resource within the clinical workflow is important to maintain high quality of care while eliminating unnecessary testing or treatment that lacks evidence-based support. Using the clinical guidelines with evidence in UpToDate helps support our efforts to improve quality metrics.”

Peter Bonis, MD, Chief Medical Officer, Clinical Effectiveness at Wolters Kluwer commented, “Embedding UpToDate into the Epic system saves clinicians time by eliminating unnecessary steps and clicks, providing the fastest possible access to diagnosis and treatment recommendations. This combination can help ARC’s healthcare professionals consistently and efficiently deliver the highest standards of care in the communities they serve.”

Follow UpToDate on Facebook, Twitter and LinkedIn.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

EN
28/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

Marc Zwartsenburg ... (+2)
  • Marc Zwartsenburg
  • CEFA

ING Benelux Favourites/Weekly performance and valuation update

We update the performance of our ING Benelux Favourites list as well as all valuation and ranking tables for our coverage universe. Performance on the front page is dated from the 19 September 2025, while historical performance is included on the second page. The methodology for our favourites selection is based on a bottom-up approach with a focus on absolute performance with clear near-term triggers. It is a rolling list, ie, stocks can enter/exit whenever we think opportune.

 PRESS RELEASE

Share Buyback Transaction Details December 18 – December 30, 2025

Share Buyback Transaction Details December 18 – December 30, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 18 – December 30, 2025 Alphen aan den Rijn – December 31, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 264,510 of its own ordinary shares in the period from December 18, 2025, up to and including December 30, 2025, for €23.7 million and at an average share price of €89.54. These repurchases are part of the share buybac...

 PRESS RELEASE

Share Buyback Transaction Details December 11 – December 17, 2025

Share Buyback Transaction Details December 11 – December 17, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 11 – December 17, 2025 Alphen aan den Rijn – December 18, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 238,453 of its own ordinary shares in the period from December 11, 2025, up to and including December 17, 2025, for €21.4 million and at an average share price of €89.85. These repurchases are part of the share buyback...

 PRESS RELEASE

Share Buyback Transaction Details December 4 – December 10, 2025

Share Buyback Transaction Details December 4 – December 10, 2025 PRESS RELEASE                                         Share Buyback Transaction Details December 4 – December 10, 2025 Alphen aan den Rijn – December 11, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 209,603 of its own ordinary shares in the period from December 4, 2025, up to and including December 10, 2025, for €18.7 million and at an average share price of €89.33. These repurchases are part of the share buyback pr...

David Vagman ... (+5)
  • David Vagman
  • CFA
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Wolters Kluwer/AI winner at an attractive valuation/BUY

Our conviction in the Wolters Kluwer investment case remains high. Three positives stand out in our view. Firstly, current trading is solid, with 9M25 organic revenue growth beating expectations. Secondly, the company's expert curated (proprietary) content is a strong moat vs AI-only alternatives as the company operates in high-stake environments where reliability is key. Thirdly, valuation has become highly attractive. We slightly lower our target price to €160 per share (from €173). We keep ou...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch